ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

Contributed by: PR Newswire

Tags

ESCMID-Global

More Like This

RSV vaccine highly effective in preventing hospitalisation

New RSV vaccine could prevent 5,000 infant hospitalisations

National RSV vaccination programme announced

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

Whooping cough cases rise to over 10,000

Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345